Valeant steps in to work on psoriasis drug with AstraZeneca
Canadian drugmaker Valeant will work with British competitor AstraZeneca on a potential treatment for psoriasis a few months after biotech giant Amgen said it was ending research on the drug because of a link to suicidal ...
Sep 1, 2015
0
3